Innovative care delivery programs intended to improve quality and reduce costs need sustainable business models in order to last beyond the end of grants or other methods of time-limited funding. RAND researchers take a look at methods Massachusetts health plans and accountable care organizations are using.
Payers and providers using new payment methods to align financial incentives with quality improvement and cost reduction goals may be relying on grants or related funding methods to test pilots; however, these only provide time-limited support. These programs must have a sustainable business model if they are to last beyond the end of grant funding, according to a study from RAND Corporation.
The researchers used a sample of 7 health plans and 5 accountable care organizations (ACOs) in Massachusetts to identify paths to sustainability for innovate care delivery programs.
“Dynamics in the current environment suggest that innovation will likely be concentrated in health care delivery systems that are able to manage financial risk and that have experience and capacity in delivery innovation,” the authors wrote. “For providers seeking to innovate, the central challenge will be building the capacity to manage financial risk in global payment arrangements and to support improvements in care.”
Among the health plans and ACOs studied, the most common short-term objective of innovative care delivery programs intended to improve quality and reduce costs was to improve the coordination of care for the highest-risk patients.
The 2 criteria most often used by study participants to assess innovative care delivery programs are scale and impact, which depend on the number of relevant and affected patients as well as the potential for improvement in quality and reductions in healthcare costs for the population.
In addition, the researchers found that while savings can be a potentially important factor when determining which care delivery program to invest in, the program does not have to demonstrate cost savings in a pilot prior to investment.
Study participants indicated that the healthcare payment environment still needs to shift farther from fee-for-service in order to meaningfully support care delivery innovation. Respondents also highlighted a lack of alignment across payers and care delivery programs. Lastly, they suggested a better understanding of the costs and effects of care delivery transformation is still needed.
“We found widespread interest and activity in testing new care delivery models to improve health care quality and reduce costs in Massachusetts,” the authors concluded. “However, the environment presents great uncertainty for the sustainability of these programs.”
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More